Multiple system atrophy (MSA) is a progressive neurodegenerative disease defined by the accumulation of alpha-synuclein protein inside oligodendrocytes, the myelin-forming cells of the central nervous system, together with selective degeneration of the striatonigral and olivopontocerebellar systems. Why certain brain regions succumb while others resist for longer has remained an open question, and a new study in Cellular and Molecular Neurobiology addresses it by mapping gene-expression changes in a mouse model of the disease.
Researchers led by Antonio Heras-Garvin, Sarah Wilhelmer, Galina Apostolova, Gregor K. Wenning and Nadia Stefanova used the PLP-alphaSyn mouse model, in which alpha-synuclein is expressed in oligodendrocytes. The model reproduces key features of human MSA, showing progressive striatonigral degeneration and later cerebellar involvement, making it a suitable platform for asking when and where molecular changes appear relative to visible neuronal loss.
The team performed bulk RNA sequencing of ventral midbrain tissue, including the substantia nigra, from PLP-alphaSyn mice and wildtype controls at two ages: 2 months and 12 months. The earlier time point was chosen because it precedes overt dopaminergic neuronal loss, allowing the investigators to test whether transcriptional disruption precedes detectable degeneration.
The results show that it does. At 2 months, before any overt loss of dopaminergic neurons, the ventral midbrain of PLP-alphaSyn mice already displayed marked dysregulation. Programs related to RNA processing and synaptic function were increased, while pathways governing mitochondrial function, metabolism and myelin maintenance were reduced.
By 12 months of age, these alterations had persisted and deepened. The older mice showed stronger suppression of oxidative phosphorylation, mitochondrial inner membrane and respiratory-chain complexes, fatty-acid and lipid metabolism, and myelin maintenance. In other words, the bioenergetic and oligodendroglial-support deficits were not a transient early response but a progressive transcriptional signature that tracked the advancing disease.
To probe regional vulnerability directly, the researchers compared these ventral midbrain findings with cerebellar transcriptomic data from the same model. The comparison revealed a clear temporal and spatial pattern: mitochondrial and myelin-related impairments emerged earlier and more strongly in the ventral midbrain than in the cerebellum, where related signatures became more evident only at later disease stages.
The authors emphasize that the findings identify early and progressive transcriptional dysregulation of bioenergetic, metabolic and oligodendroglial and myelin-support programs in experimental MSA, and highlight these processes as candidate contributors to regional vulnerability in this model.
Several caveats frame the work. The study was conducted in a transgenic mouse model rather than human tissue, and bulk RNA sequencing averages signals across mixed cell populations, so cell-type-specific contributions cannot be resolved from these data alone. The findings are associations between oligodendroglial alpha-synucleinopathy and transcriptional states, not demonstrations of causal mechanisms, and the paper is being shared early as a peer-reviewed, accepted version subject to further edits before the final Version of Record.
Even with those limitations, the study offers a molecular timetable for MSA-like pathology: energy metabolism and myelin-support programs falter in the ventral midbrain long before neurons die, and the same deficits arrive late in the comparatively spared cerebellum.
Subject of Research: Transcriptional changes linked to oligodendroglial alpha-synucleinopathy and regional nigral vulnerability in a mouse model of multiple system atrophy.
Article Title: Oligodendroglial α-Synucleinopathy Remodels Transcriptional Programs Associated with Nigral Vulnerability in Experimental Multiple System Atrophy
Article References: Heras-Garvin, A., Wilhelmer, S., Apostolova, G., Wenning, G. K., & Stefanova, N. (2026). Oligodendroglial α-Synucleinopathy Remodels Transcriptional Programs Associated with Nigral Vulnerability in Experimental Multiple System Atrophy. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01839-y
Image Credits: AI Generated
DOI: 10.1007/s10571-026-01839-y
Keywords: multiple system atrophy, alpha-synuclein, oligodendrocytes, substantia nigra, RNA sequencing, mitochondrial dysfunction, myelin, PLP-alphaSyn mouse model, neurodegeneration, regional vulnerability, oxidative phosphorylation, cerebellum
News Source: Juliet Wilcox. (October 28, 2026). Oligodendroglial Alpha-Synuclein Rewires Midbrain Gene Programs Before Nigral Cell Loss in Mouse Model of MSA. Scienmag.



